CI
HZNP

Cigna Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Cigna Investments’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,399
Closed -$277K – 451
2023
Q3 		$277K Hold
2,399
– – 0.06% 324
2023
Q2 		$247K Hold
2,399
– – 0.05% 391
2023
Q1 		$262K Sell
2,399
-53
-2% -$5.86K 0.05% 371
2022
Q4 		$279K Buy
+2,452
New +$204K 0.06% 353
2022
Q2 		– Sell
-2,294
Closed -$241K – 594
2022
Q1 		$241K Buy
+2,294
New +$224K 0.03% 509
2019
Q2 		– Sell
-7,594
Closed -$201K – 734
2019
Q1 		$201K Buy
+7,594
New +$180K 0.02% 648

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cigna Investments's HZNP Position: Q4 2023 in Review

Cigna Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,399 shares — an estimated $277K sold.

Cigna Investments first reported a position in HZNP in Q1 2019 and held it in 6 quarters. The position peaked at $279K in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Cigna Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Cigna Investments sold 2,399 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $277K.
  • Cigna Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 6 quarters.
  • Cigna Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $279K in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Cigna Investments's 13F filing for Q4 2023, filed 22 Jan 2024.